tiprankstipranks
Trending News
More News >
FB CARE SERVICE CO.,LTD. (JP:9220)
:9220
Japanese Market
Advertisement

FB CARE SERVICE CO.,LTD. (9220) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9220

FB CARE SERVICE CO.,LTD.

(9220)

Select Model
Select Model
Select Model
Outperform 81 (OpenAI - 4o)
Rating:81Outperform
Price Target:
¥1,491.00
▲(21.22% Upside)
FB CARE SERVICE CO.,LTD. demonstrates strong financial performance with robust revenue growth and stable margins. Technical indicators show bullish momentum, supported by a favorable valuation with a low P/E ratio and attractive dividend yield. These factors collectively contribute to a strong overall stock score.

FB CARE SERVICE CO.,LTD. (9220) vs. iShares MSCI Japan ETF (EWJ)

FB CARE SERVICE CO.,LTD. Business Overview & Revenue Model

Company DescriptionFB Care Service Co.,Ltd. provides nursing care services in Japan and internationally. It operates through Welfare Equipment and The Nursing Care Business segments. The company offers fee-based nursing homes, group homes, small-scale multi-functional in-home and nursing care, day services, home-visit care and nursing, and in home nursing care support services. It also rents and sells welfare equipment. FB Care Service Co.,Ltd. was incorporated in 1987 and is based in Saku, Japan.
How the Company Makes MoneyFB CARE SERVICE CO.,LTD. primarily generates revenue through its diverse service offerings. The company earns money from fees charged for home healthcare services, which may include nursing care, physical therapy, and personal care assistance. Additionally, revenue is generated from wellness programs, workshops, and partnerships with healthcare providers. Significant partnerships with hospitals and healthcare organizations enhance its service reach and credibility, allowing the company to tap into broader markets. Furthermore, the company may also explore subscription models for ongoing care services, providing a steady income stream.

FB CARE SERVICE CO.,LTD. Financial Statement Overview

Summary
FB CARE SERVICE CO.,LTD. is performing well with strong revenue growth and stable profitability margins. The balance sheet shows improved financial stability with reduced leverage. Cash flow generation is strong, supporting the company's operations and growth initiatives. While there are some risks related to liabilities, the overall financial health of the company is solid.
Income Statement
75
Positive
The company has shown consistent revenue growth over the years, with a notable increase from 2024 to 2025. Gross profit margin and net profit margin are stable, indicating good cost management. However, the net income has fluctuated, suggesting some volatility in profitability. The EBIT and EBITDA margins are healthy, reflecting efficient operations.
Balance Sheet
70
Positive
The balance sheet shows a strong equity position with a steady increase in stockholders' equity over the years. The debt-to-equity ratio has improved, indicating reduced leverage risk. However, the total liabilities remain significant, which could pose a risk if not managed properly. The equity ratio is improving, reflecting a stronger financial foundation.
Cash Flow
80
Positive
The company has demonstrated strong cash flow generation, with consistent operating cash flow exceeding net income. Free cash flow has grown significantly, indicating efficient capital expenditure management. The free cash flow to net income ratio is robust, highlighting effective cash utilization.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.09B10.97B10.36B9.62B9.19B9.35B
Gross Profit1.69B1.70B1.49B1.55B1.56B1.50B
EBITDA1.04B1.02B1.16B1.05B1.07B1.07B
Net Income430.43M406.36M523.43M444.93M528.70M477.20M
Balance Sheet
Total Assets9.01B8.86B9.50B9.02B7.70B8.31B
Cash, Cash Equivalents and Short-Term Investments1.78B1.96B2.36B2.37B1.79B1.87B
Total Debt2.78B2.92B3.67B3.85B3.80B4.93B
Total Liabilities5.28B5.22B6.02B5.98B5.69B6.83B
Stockholders Equity3.72B3.64B3.48B3.04B2.01B1.48B
Cash Flow
Free Cash Flow0.00812.85M465.79M207.47M864.78M946.12M
Operating Cash Flow0.001.06B1.06B969.84M898.59M1.18B
Investing Cash Flow0.00-240.41M-586.21M-849.26M-97.01M-111.66M
Financing Cash Flow0.00-1.22B-472.37M463.71M-878.81M-373.66M

FB CARE SERVICE CO.,LTD. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1230.00
Price Trends
50DMA
1207.32
Positive
100DMA
1126.77
Positive
200DMA
1026.78
Positive
Market Momentum
MACD
21.29
Positive
RSI
54.66
Neutral
STOCH
42.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9220, the sentiment is Positive. The current price of 1230 is below the 20-day moving average (MA) of 1263.05, above the 50-day MA of 1207.32, and above the 200-day MA of 1026.78, indicating a bullish trend. The MACD of 21.29 indicates Positive momentum. The RSI at 54.66 is Neutral, neither overbought nor oversold. The STOCH value of 42.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9220.

FB CARE SERVICE CO.,LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥3.04B7.502.61%5.37%-9.33%
80
Outperform
¥2.00B13.3232.45%58.25%
75
Outperform
¥3.04B9.442.50%-3.06%-38.56%
72
Outperform
¥2.54B5.404.42%2.45%205.19%
64
Neutral
¥4.37B-15.390.98%11.52%-645.05%
64
Neutral
¥1.25B14.759.76%-10.10%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9220
FB CARE SERVICE CO.,LTD.
1,222.00
329.04
36.85%
JP:2425
Care Service Co., Ltd.
791.00
-33.82
-4.10%
JP:2435
Cedar. Co.,Ltd
222.00
14.54
7.01%
JP:7037
teno.Holdings Co., Ltd.
929.00
441.77
90.67%
JP:7362
Terminalcare Support Institute, Inc.
815.00
-64.00
-7.28%
JP:9214
Recovery International Co.,Ltd.
1,411.00
85.00
6.41%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025